华润双鹤：控股子公司湘中制药奥卡西平片获得药品注册证书

Core Viewpoint - The company announced that its subsidiary, Xiangzhong Pharmaceutical, has received the Drug Registration Certificate for Oxcarbazepine Tablets from the National Medical Products Administration [1] Group 1 - The approval of Oxcarbazepine Tablets is a significant milestone for the company, indicating progress in its pharmaceutical product offerings [1] - This development may enhance the company's market position in the pharmaceutical industry, particularly in the neurology segment where Oxcarbazepine is utilized [1]